Andrew Reitinger

Andrew Reitinger has a diverse work experience spanning multiple companies and roles. Andrew began their career at Integrated DNA Technologies in 2006 as a Technical Support Specialist. In 2007, they moved on to Celsis International where they worked as a Technical Account Manager for their Rapid Microbial Detection division. After that, they joined Affymetrix in 2011 as a Business Development Manager. In 2014, Andrew joined Ambry Genetics as a Business Development Manager, focusing on neurology and pediatric genetics. Andrew then transitioned to Personalis, Inc. in 2015 as a Sales Executive, where they worked on the ACE ImmunoID technology platform for personalized immuno-oncology therapeutics and diagnostics. In 2018, Andrew joined SeraCare Life Sciences as a Business Development Manager in Clinical Genomics. Currently, they are working at Mission Bio as an Associate Director of Biopharma Business Development, where they are involved in transforming single-cell multi-omics for precision medicine.

Andrew Reitinger earned a Bachelor of Science (BS) degree in Biological and Biomedical Sciences from Colorado State University, where they studied from 2000 to 2004. Following that, they pursued Molecular Cellular and Developmental Biology (MCDB) at the University of Michigan from 2004 to 2006, although they did not obtain a degree from this institution. In terms of additional certifications, Andrew completed the Miller Heiman Sales Training program offered by the Miller Heiman Group in June 2015.